Elite Pharmaceuticals, Inc.
Elite participates in First Albany Capital's Chronic Pain Conference, discusses opioid therapy
Published in Law and Health Weekly, April 15th, 2006
Dr. Charan Behl, Elite's chief scientific officer, discussed the company's two lead opioid products: OxyNal, the company's opioid abuse-resistant oxycodone product and OxyQD, the company's once-daily oxycodone product to address the subject "Unmet Needs in Opioid Therapy."
OxyNal uses a pharmacological agonist-antagonist combination approach of sustained release agonist oxycodone hydrochloride, intended for use in patients with moderate to severe chronic pain, and an antagonist, naltrexone hydrochloride, formulated to deter abusers of the drug.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- American College of Cardiology
Researchers find viable new sources for stem cell transplants to the heart - Colon Cancer
Physicians warn too few Americans getting screened for colon cancer - End-of-Life Issues
Advance planning can help family members make decisions at end of life - Evercare
Evercare launches educational outreach program to answer Medicare Part D questions - Inex Pharmaceuticals Corp.
Inex licenses three targeted chemotherapy products to Hana Biosciences - Information Technology
Verispan's informatics software identifies top 10 drug classes affected by Medicare Part D - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
